Osstem Implant Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was KRW 4,357.69 million compared to KRW 3,524.12 million a year ago. Net income was KRW 154,778.35 million compared to KRW 101,124.37 million a year ago. Basic earnings per share from continuing operations was KRW 106,717 compared to KRW 75,107 a year ago. Diluted earnings per share from continuing operations was KRW 105,777 compared to KRW 38,346 a year ago. Basic earnings per share was KRW 106,717 compared to KRW 75,107 a year ago. Diluted earnings per share was KRW 105,777 compared to KRW 38,346 a year ago.